1778-2315 Screening compound: N-(1,3-benzothiazol-2-yl)-4-fluorobenzamide

1778-2315 Screening compound: N-(1,3-benzothiazol-2-yl)-4-fluorobenzamide
1778-2315 Screening compound: N-(1,3-benzothiazol-2-yl)-4-fluorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 1778-2315
N-(1,3-benzothiazol-2-yl)-4-fluorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

1778-2315

Molecular Formula

C14H9FN2OS (C14 H9 FN2 OS)

Compound Name

N-(1,3-benzothiazol-2-yl)-4-fluorobenzamide

IUPAC name

N-(13-benzothiazol-2-yl)-4-fluorobenzamide

SMILES

O=C(c(cc1)ccc1F)Nc1nc(cccc2)c2s1

InChI

InChI=1S/C14H9FN2OS/c15-10-7-5-9(6-8-10)13(18)17-14-16-11-3-1-2-4-12(11)19-14/h1-8H,(H,16,17,18)

InChI Key

HVWMIWALOMXMOR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00247502

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

272.3

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

3.919

Distribution Coefficient, logD

3.905

Water Solubility, LogSw

-4.29

Polar Surface Area

33.091

Acid Dissociation Constant (pKa)

8.88

Base Dissociation Constant (pKb)

-0.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

1778-2315 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-infective Library (19449 compounds)

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Antiviral Library (67538 compounds)

CNS targets activity set (6557 compounds)

Frequent Hitters Library (7624 compounds)

Human Receptors Annotated Library (5376 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Structure:
  • Pool

References: we are preparing a list of scientific research reports with 1778-2315 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 1778-2315?
Check Price and Availability of 1778-2315, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 1778-2315 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 1778-2315
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 1778-2315
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 1778-2315 available by request